People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Pharmaceuticals, Other Technology, Other Energy, Computers
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Concentric Analgesics, Inc. | — | Biotechnology | Series C | $130.8M | $477.6M | 2017 |
| Faraday Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $115.5M | $829.7M | 2014 |
| Energysavvy Inc | — | Other Technology | Series A | $31.2M | $390.1M | 2015 |
| Satsuma Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $12.1M | $375.8M | 2016 |
| Thermasource Llc | — | Other Energy | Series A | $8.0M | $84.5M | 2009 |
| Black Ice Data Inc. | — | Computers | Pre-Seed | $250K | $1.2M | 2024 |
Thomas King at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas King on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Robert Nelsen | 1 | 22 |
| Michael Galgon | 1 | 14 |
| Michael Hoffman | 1 | 11 |
| Tim Woodward | 1 | 10 |
| Heath Lukatch | 1 | 10 |
| Terrance McGuire | 1 | 9 |
| John Donovan | 1 | 8 |
| Paulina Hill | 1 | 5 |
| Rajeev Shah | 1 | 4 |
| Dennis Odell | 1 | 3 |
| Stephen Hill | 1 | 3 |
| Karl Siebrecht | 1 | 3 |
| Lawrence Gozlan | 1 | 3 |
| Mark Roth | 1 | 3 |
| Bradley Zenger | 1 | 2 |
| Aaron Goldfeder | 1 | 2 |
| Frank Bellizzi | 1 | 2 |
| Dean Sciorillo | 1 | 1 |
| Scott Case | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.